Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SOFDRA™ safely and effectively. See full prescribing information for SOFDRA. SOFDRA (sofpironium) topical gel, 12.45% Initial U.S. Approval: 2024
Medication labelWhy this: Advisory · dailymed-prescription
SOFDRA is indicated for the treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older.
- generic_name
- sofpironium bromide
- product_names
- sofpironium bromide
- ndc
- 83723-010, 83723-010-50
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en